ATE533061T1 - Verfahren zur diagnose bakterieller infektionen - Google Patents
Verfahren zur diagnose bakterieller infektionenInfo
- Publication number
- ATE533061T1 ATE533061T1 AT10188288T AT10188288T ATE533061T1 AT E533061 T1 ATE533061 T1 AT E533061T1 AT 10188288 T AT10188288 T AT 10188288T AT 10188288 T AT10188288 T AT 10188288T AT E533061 T1 ATE533061 T1 AT E533061T1
- Authority
- AT
- Austria
- Prior art keywords
- patient
- bacterial infections
- diagnosing bacterial
- risk
- diagnosing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/585—Calcitonins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07015271A EP2020603A1 (de) | 2007-08-03 | 2007-08-03 | Verfahren zur Einteilung von Risikoklassen bei stabiler Erkrankung der Koronaraterien |
EP08152651A EP2101178A1 (de) | 2008-03-12 | 2008-03-12 | Verwendung von Procalcitonin zur Prognose folgender akuter Koronarsyndromen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE533061T1 true ATE533061T1 (de) | 2011-11-15 |
Family
ID=39745280
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08786791T ATE514091T1 (de) | 2007-08-03 | 2008-08-01 | Verwendung von procalcitonin (pct) zur risikostratifikation und prognose bei patienten mit einer primären nichtinfektiösen krankheit |
AT10188288T ATE533061T1 (de) | 2007-08-03 | 2008-08-01 | Verfahren zur diagnose bakterieller infektionen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08786791T ATE514091T1 (de) | 2007-08-03 | 2008-08-01 | Verwendung von procalcitonin (pct) zur risikostratifikation und prognose bei patienten mit einer primären nichtinfektiösen krankheit |
Country Status (9)
Country | Link |
---|---|
US (3) | US20110136161A1 (de) |
EP (4) | EP2293076B1 (de) |
JP (2) | JP5059943B2 (de) |
CN (3) | CN110346577A (de) |
AT (2) | ATE514091T1 (de) |
DE (1) | DE602008021800C5 (de) |
ES (3) | ES2377112T3 (de) |
HK (1) | HK1183707A1 (de) |
WO (1) | WO2009019230A2 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110346577A (zh) | 2007-08-03 | 2019-10-18 | B.R.A.H.M.S 有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
DK2419741T3 (da) * | 2009-04-14 | 2019-11-04 | Brahms Gmbh | Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin |
JP5731489B2 (ja) * | 2009-06-05 | 2015-06-10 | ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 呼吸困難を起こした患者における細菌感染の検出 |
WO2011023813A1 (en) | 2009-08-28 | 2011-03-03 | Brahms Gmbh | Procalcitonin for the prognosis of adverse events |
ES2601104T3 (es) * | 2009-10-13 | 2017-02-14 | B.R.A.H.M.S Gmbh | Procalcitonina para el diagnóstico de infecciones bacterianas y la guía del tratamiento antibiótico en pacientes con apoplejía aguda o accidente isquémico transitorio |
WO2011110565A1 (en) * | 2010-03-08 | 2011-09-15 | B.R.A.H.M.S Gmbh | Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints |
ITRM20100121A1 (it) * | 2010-03-18 | 2011-09-19 | Univ Pisa | Marcatori molecolari per infezioni delle vie urinarie. |
EP3032261B1 (de) * | 2010-06-18 | 2018-05-23 | B.R.A.H.M.S GmbH | Mr-pro-amd für die vorhersage der inzidenz eines karzinoms in mänlichen patienten unter 57.9 jahre. |
US20130024205A1 (en) * | 2011-07-18 | 2013-01-24 | International Business Machines Corporation | Dynamically updating electronic medical records and leveraging a person's path in a facility to mitgate risks |
ES2679107T3 (es) | 2012-02-09 | 2018-08-22 | Memed Diagnostics Ltd. | Distintivos y determinantes para diagnosticar infecciones y métodos para usarlos |
US9488659B2 (en) * | 2012-04-12 | 2016-11-08 | B.R.A.H.M.S. Gmbh | Prognosis of adverse events in patients with suspected chronic heart failure |
WO2013173778A1 (en) | 2012-05-18 | 2013-11-21 | Critical Care Diagnostics, Inc. | Methods for treating or predicting risk of a ventricular tachyarrhythmia event |
ES2656897T3 (es) * | 2012-08-16 | 2018-02-28 | Critical Care Diagnostics, Inc. | Procedimientos de predicción del riesgo de desarrollar hipertensión |
CA2891509C (en) * | 2012-11-15 | 2021-05-11 | Ortho-Clinical Diagnostics, Inc. | Calibrating assays using reaction time |
KR20170041907A (ko) | 2014-08-14 | 2017-04-17 | 메메드 다이어그노스틱스 리미티드 | 매니폴드 및 초평면을 이용한 생물학적 데이터의 컴퓨터 분석법 |
US20170234873A1 (en) | 2014-10-14 | 2017-08-17 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof |
CA3012985A1 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
EP3309553A4 (de) * | 2015-06-09 | 2019-02-13 | Osaka University | Verfahren zur vorhersage/beurteilung der wirksamkeit eines biologischen präparats bei rheumatoider arthritis |
CN108699583B (zh) | 2016-03-03 | 2022-11-01 | 米密德诊断学有限公司 | 用于区分细菌和病毒感染的rna决定子 |
CN106093416B (zh) * | 2016-05-18 | 2018-10-12 | 北京北方生物技术研究所有限公司 | 一种一步法检测降钙素原的试剂盒及其制备方法 |
EP4184167A1 (de) | 2016-07-10 | 2023-05-24 | MeMed Diagnostics Ltd. | Frühdiagnose von infektionen |
CN109661578B (zh) | 2016-07-10 | 2022-05-10 | 米密德诊断学有限公司 | 用于区分细菌和病毒感染的蛋白质特征 |
EP3519833A4 (de) | 2016-09-29 | 2020-06-03 | MeMed Diagnostics Ltd. | Verfahren zur prognose und behandlung |
US11353456B2 (en) | 2016-09-29 | 2022-06-07 | Memed Diagnostics Ltd. | Methods of risk assessment and disease classification for appendicitis |
CN111094981B (zh) * | 2017-09-13 | 2024-04-16 | B.R.A.H.M.S有限公司 | Pct和pro-adm作为监测抗生素治疗的标记物 |
CN111656189A (zh) * | 2017-12-20 | 2020-09-11 | B.R.A.H.M.S有限公司 | 基于合并症患者的降钙素原的抗生素疗法指导 |
US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
CN116762011A (zh) * | 2020-12-02 | 2023-09-15 | 贝克曼库尔特有限公司 | 发展成脓毒症的概率的检测 |
EP4330679A2 (de) | 2021-04-30 | 2024-03-06 | Roche Diagnostics GmbH | Esm1-markertafeln zur frühen erkennung von sepsis |
CN117321419A (zh) | 2021-04-30 | 2023-12-29 | 豪夫迈·罗氏有限公司 | 用于脓毒症的早期检测的Presepsin标志物组 |
WO2022229421A2 (en) | 2021-04-30 | 2022-11-03 | F. Hoffmann-La Roche Ag | Strem1 marker panels for early detection of sepsis |
JP2024516680A (ja) | 2021-04-30 | 2024-04-16 | エフ. ホフマン-ラ ロシュ アーゲー | 敗血症の早期検出用のil6マーカーパネル |
WO2022229422A2 (en) | 2021-04-30 | 2022-11-03 | Roche Diagnostics Gmbh | Igfbp7 marker panels for early detection of sepsis |
EP4330688A2 (de) | 2021-04-30 | 2024-03-06 | Roche Diagnostics GmbH | Pct-markerpanels zur früherkennung von sepsis |
JP2024516677A (ja) | 2021-04-30 | 2024-04-16 | エフ. ホフマン-ラ ロシュ アーゲー | 敗血症の早期検出用のngalマーカーパネル |
JP2024515086A (ja) | 2021-04-30 | 2024-04-04 | エフ. ホフマン-ラ ロシュ アーゲー | 敗血症の早期検出のためのgdf15マーカーパネル |
WO2022229440A2 (en) | 2021-04-30 | 2022-11-03 | F. Hoffmann-La Roche Ag | Sflt1 marker panels for early detection of sepsis |
WO2023052446A1 (en) | 2021-09-29 | 2023-04-06 | F. Hoffmann-La Roche Ag | Mr-proadm marker panels for early detection of sepsis |
WO2023156655A1 (en) | 2022-02-21 | 2023-08-24 | F. Hoffmann-La Roche Ag | Dll1 marker panels for early detection of sepsis |
EP4357778A1 (de) | 2022-10-20 | 2024-04-24 | Heraeus Medical GmbH | Behandlung von mikrobiellen infektionen mit diagnose durch biomarker d-lactat |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4227454C1 (de) * | 1992-08-19 | 1994-02-03 | Henning Berlin Gmbh | Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens |
US6147688A (en) | 1993-06-28 | 2000-11-14 | Athena Design Systems, Inc. | Method and apparatus for defining and selectively repeating unit image cells |
US5795725A (en) | 1995-04-18 | 1998-08-18 | Biosite Diagnostics Incorporated | Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays |
DE19600875C1 (de) * | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
US6156521A (en) | 1997-12-19 | 2000-12-05 | Biosite Diagnostics, Inc. | Methods for the recovery and measurement of troponin complexes |
US5993811A (en) * | 1997-02-03 | 1999-11-30 | Biology Associates, Llc | Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
DE19903336C2 (de) | 1999-01-28 | 2000-12-14 | Brahms Diagnostica Gmbh | Gebrauchsfertige Kalibratoren für die Bestimmung von Procalcitonin |
US7632647B2 (en) | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
US20040253637A1 (en) * | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
AU2002305394A1 (en) * | 2001-05-04 | 2002-11-18 | Biosite, Inc. | Diagnostic markers of acute coronary syndromes and methods of use thereof |
CA2511501A1 (en) | 2002-12-24 | 2004-07-15 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
DE10316583A1 (de) * | 2003-04-10 | 2004-10-28 | B.R.A.H.M.S Aktiengesellschaft | Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung |
US7341838B2 (en) | 2003-04-17 | 2008-03-11 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
US20050148029A1 (en) | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
DE112004001863T5 (de) * | 2003-10-03 | 2006-09-07 | Scantibodies Laboratory, Inc., Santee | Verfahren und Verwendung von Bindungskomponenten zur Verbesserung der Testspezifität |
CA2485722A1 (en) | 2003-10-22 | 2005-04-22 | Paul Lehmann | Soluble transferrin receptor |
ATE312351T1 (de) | 2004-02-13 | 2005-12-15 | Brahms Ag | Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens |
US20060024744A1 (en) | 2004-07-28 | 2006-02-02 | Mills Rhonda A | Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte |
DE102004041659A1 (de) | 2004-08-27 | 2006-03-02 | Institut Virion/Serion Gmbh | Testvorrichtung für die in vitro Diagnostik von Multianalyt-Tests und deren Verwendung |
AU2006264175B2 (en) | 2005-06-28 | 2012-01-12 | Zbx Corporation | Membrane array and analytical device |
DE102005034174A1 (de) | 2005-07-21 | 2007-02-08 | B.R.A.H.M.S Ag | Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen |
WO2007041623A2 (en) * | 2005-10-03 | 2007-04-12 | Biosite Incorporated | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
CN1800384A (zh) * | 2005-11-08 | 2006-07-12 | 浙江大学 | 降钙素原的制备方法 |
US20070224643A1 (en) | 2006-03-09 | 2007-09-27 | Mcpherson Paul H | Methods and compositions for the diagnosis of diseases of the aorta |
DE102006046996A1 (de) | 2006-10-01 | 2008-04-03 | Brahms Aktiengesellschaft | Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz |
CN110346577A (zh) * | 2007-08-03 | 2019-10-18 | B.R.A.H.M.S 有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
EP2020603A1 (de) | 2007-08-03 | 2009-02-04 | BRAHMS Aktiengesellschaft | Verfahren zur Einteilung von Risikoklassen bei stabiler Erkrankung der Koronaraterien |
DE102008037108A1 (de) | 2008-08-08 | 2010-02-11 | Samson Aktiengesellschaft | System zum Stellen eines Stellorgans |
ES2601104T3 (es) * | 2009-10-13 | 2017-02-14 | B.R.A.H.M.S Gmbh | Procalcitonina para el diagnóstico de infecciones bacterianas y la guía del tratamiento antibiótico en pacientes con apoplejía aguda o accidente isquémico transitorio |
US20110263438A1 (en) | 2010-04-22 | 2011-10-27 | Mehmet Ali Soylemez | Diagnosis and complication risk assessment of pancreatic diabetes using procalcitonin |
-
2008
- 2008-08-01 CN CN201910283751.1A patent/CN110346577A/zh active Pending
- 2008-08-01 WO PCT/EP2008/060176 patent/WO2009019230A2/en active Application Filing
- 2008-08-01 ES ES10188288T patent/ES2377112T3/es active Active
- 2008-08-01 CN CN201210451017.XA patent/CN103123359B/zh active Active
- 2008-08-01 EP EP10188289A patent/EP2293076B1/de active Active
- 2008-08-01 EP EP10188288A patent/EP2293078B1/de active Active
- 2008-08-01 CN CN200880101846A patent/CN101790687A/zh active Pending
- 2008-08-01 EP EP08786791A patent/EP2174143B1/de active Active
- 2008-08-01 ES ES10188287T patent/ES2403310T3/es active Active
- 2008-08-01 EP EP10188287A patent/EP2301626B1/de active Active
- 2008-08-01 AT AT08786791T patent/ATE514091T1/de active
- 2008-08-01 AT AT10188288T patent/ATE533061T1/de active
- 2008-08-01 JP JP2010518695A patent/JP5059943B2/ja active Active
- 2008-08-01 DE DE602008021800.7A patent/DE602008021800C5/de active Active
- 2008-08-01 US US12/671,702 patent/US20110136161A1/en not_active Abandoned
- 2008-08-01 ES ES10188289T patent/ES2401703T3/es active Active
-
2011
- 2011-02-25 US US13/034,752 patent/US10456364B2/en active Active
-
2012
- 2012-08-02 JP JP2012171897A patent/JP5185460B2/ja active Active
-
2013
- 2013-09-27 HK HK13111067.0A patent/HK1183707A1/xx unknown
-
2019
- 2019-03-29 US US16/369,966 patent/US11241395B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2293076A3 (de) | 2011-03-30 |
WO2009019230A4 (en) | 2009-06-25 |
EP2301626B1 (de) | 2013-01-16 |
CN103123359A (zh) | 2013-05-29 |
US20110136161A1 (en) | 2011-06-09 |
JP5185460B2 (ja) | 2013-04-17 |
US10456364B2 (en) | 2019-10-29 |
US11241395B2 (en) | 2022-02-08 |
EP2293078B1 (de) | 2011-11-09 |
EP2174143B1 (de) | 2011-06-22 |
JP5059943B2 (ja) | 2012-10-31 |
US20110152170A1 (en) | 2011-06-23 |
CN110346577A (zh) | 2019-10-18 |
EP2301626A3 (de) | 2011-11-16 |
CN101790687A (zh) | 2010-07-28 |
ATE514091T1 (de) | 2011-07-15 |
US20190224135A1 (en) | 2019-07-25 |
EP2293076A2 (de) | 2011-03-09 |
JP2010536012A (ja) | 2010-11-25 |
HK1183707A1 (en) | 2014-01-03 |
WO2009019230A3 (en) | 2009-04-23 |
WO2009019230A2 (en) | 2009-02-12 |
EP2174143A2 (de) | 2010-04-14 |
ES2377112T3 (es) | 2012-03-22 |
CN103123359B (zh) | 2015-07-29 |
EP2301626A2 (de) | 2011-03-30 |
ES2401703T3 (es) | 2013-04-23 |
ES2403310T3 (es) | 2013-05-17 |
EP2293078A3 (de) | 2011-04-06 |
EP2293076B1 (de) | 2012-12-19 |
DE602008021800C5 (de) | 2022-05-05 |
EP2293078A2 (de) | 2011-03-09 |
JP2012237760A (ja) | 2012-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE533061T1 (de) | Verfahren zur diagnose bakterieller infektionen | |
ATE436018T1 (de) | Verbesserte immuntestverfahren | |
EP2596132A4 (de) | Verfahren zur erkennung von anzeichen für krankheiten oder leiden in körperflüssigkeiten | |
WO2010041046A8 (en) | Granin proteins as markers of heart disease | |
ATE483982T1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
SG171691A1 (en) | Biomarkers for diagnosing multiple sclerosis, and methods thereof | |
AR088244A1 (es) | oxMIF COMO MARCADOR DE DIAGNOSTICO | |
ATE454630T1 (de) | Verfahren zur diagnose einer erkrankung mit beteiligung eines anti-at1-rezeptor-antikörpers | |
ATE406579T1 (de) | Verfahren zur diagnose von tumoren | |
DE602006020850D1 (de) | Biomarker zur diagnose einer herzerkrankung sowie verwendung davon | |
ES2619569T3 (es) | Método de ensayo de infección o inflamación de las vías respiratorias inferiores | |
DE602006018145D1 (de) | Verfahren zur diagnose und behandlung auf nr2-peptiden beruhender zerebrovaskulärer ereignisse | |
DE602006015221D1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
BR112013030646A2 (pt) | uso diagnóstico de pró-somatostatina | |
FR2946349B1 (fr) | Sequences, anticorps, procedes et necessaires pour la detection et le dosage in vitro de la periostine, en vue du diagnostic du suivi ou du pronostic de pathologies ou de phenomenes biologiques impliquant la periostine | |
ES2570609T3 (es) | Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal | |
EA201490576A1 (ru) | Молекулярный маркер для ранней диагностики мезотелиомы плевры у пациентов и способы для анализа его экспрессии | |
BR112012023485A2 (pt) | marcadores moleculares para infecções do trato urinário. | |
GB0706558D0 (en) | Diagnostic assay | |
MY147511A (en) | Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage-a3-marker | |
WO2010093214A3 (en) | Monoclonal antibody recognizing scye1 and use thereof | |
DE602005023973D1 (de) | Verfahren zur diagnose von chronischem stress und verwandten erkrankungen | |
FR2918996B1 (fr) | Procede et kits de diagnostic et de pronostic de tumeurs endocrines, et en particulier de tumeurs de l'hypophyse | |
UA35984U (ru) | Способ дифференциальной диагностики ранних стадий остеоартрозов больших суставов | |
PL422611A1 (pl) | Sposób wykrywania uszkodzenia nerek pojawiającego się u chorych z cukrzycą |